Neomatrix Therapeutics, Inc.

This study tests a single dose of a new drug called cP12 in 6 adults who have small thermal burns (up to 10% of their body surface). The main goal is to check if the drug is safe and how the body processes it. Participants receive the drug within 2 to 24 hours after the burn and …